Tom Vician

Analyst Articles

Today’s pick is what I like to call an “extreme growth stock.” It’s a pharmaceutical company seeing significant advances in sales and earnings with huge momentum. Shares are up nearly 150% in the past two years, and they look ready to move even higher in the weeks and months to come. … Read More

The U.S. stock market has been the darling of the world this year. The trifecta of a strengthening economy, a stronger greenback and decreasing commodity prices helped drive U.S. corporate profits. Foreign and domestic money flowed into U.S. stocks, pushing the S&P 500 and Dow Jones Industrial Average to record… Read More